@xconomy.com 4 months ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com 9 months ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com 10 months ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com 10 months ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com 1 year ago
New Funds for Procyrion, Remedy, OncoNano, Vyopta & More TX Tech
@xconomy.com 1 year ago
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans
@xconomy.com 1 year ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com 1 year ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com 1 year ago
RiverVest Venture Closes $184M Fund for Backing Healthcare Ventures
@xconomy.com 1 year ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com 1 year ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com 1 year ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com 2 years ago
OncoNano, Maker of Tumor Imaging Technology, Raises $11.7 Million
@Murph_CJ 3 years ago
RT @DrWeidner: AstraZeneca plans new connected inhaler trial to improve medication adherence in COPD patients | #digitalhealth http://mobihealthnews.com/content/astrazeneca-plans-new-connected-inhaler-trial-improve-medication-adherence-copd-patients